In a semiquantitative analysis of neutrophil-specific and apoptosis-specific markers in 35 CRC patients, 71.4% of patients were found to express CD66b, cleaved caspase-3, M30, as well as IL-8 in CRC pseudolumina (Fig. 4E). This evidence concerns the gene CXCL8 and colorectal carcinoma.